These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 28355985)

  • 1. Cessation of oral anticoagulants in antiphospholipid syndrome.
    Comarmond C; Jego P; Veyssier-Belot C; Marie I; Mekinian A; Elmaleh-Sachs A; Leroux G; Saadoun D; Oziol E; Fraisse T; Hyvernat H; Thiercein-Legrand MF; Sarrot-Reynauld F; Ferreira-Maldent N; de Menthon M; Goujard C; Khau D; Nguen Y; Monnier S; Michon A; Castel B; Decaux O; Piette JC; Cacoub P
    Lupus; 2017 Oct; 26(12):1291-1296. PubMed ID: 28355985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of direct oral anticoagulants in antiphospholipid syndrome.
    Cohen H; Efthymiou M; Isenberg DA
    J Thromb Haemost; 2018 Jun; 16(6):1028-1039. PubMed ID: 29624847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulation withdrawal in antiphospholipid syndrome: a retrospective matched-control study.
    Yelnik CM; Urbanski G; Drumez E; Caron C; Maillard H; Morell-Dubois S; Dubucquoi S; Launay D; Hachulla E; Hatron PY; Duhamel A; Lambert M
    Lupus; 2018 Mar; 27(3):357-364. PubMed ID: 28728511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bleeding and recurrent thrombosis in definite antiphospholipid syndrome: analysis of a series of 66 patients treated with oral anticoagulation to a target international normalized ratio of 3.5.
    Ruiz-Irastorza G; Khamashta MA; Hunt BJ; Escudero A; Cuadrado MJ; Hughes GR
    Arch Intern Med; 2002 May; 162(10):1164-9. PubMed ID: 12020188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Choice of anticoagulation in patients with low risk antiphospholipid syndrome.
    Bakow BR; Phung Q; Rabinovich D; Olszewski AJ; Reagan JL
    J Thromb Thrombolysis; 2023 Jul; 56(1):121-127. PubMed ID: 37219825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct oral anticoagulants: an alternative treatment for thrombotic antiphospholipid syndrome?
    Resseguier AS; Pereira B; Rieu V; Le Guenno G; Grobost V; Ruivard M
    Lupus; 2017 Oct; 26(12):1297-1303. PubMed ID: 28355988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of direct oral anticoagulants in 56 patients with antiphospholipid syndrome.
    Malec K; Góralczyk T; Undas A
    Thromb Res; 2017 Apr; 152():93-97. PubMed ID: 27989533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients with antiphosholipid syndrome and thrombotic recurrences: A real world observation (the Piedmont cohort study).
    Bazzan M; Vaccarino A; Stella S; Sciascia S; Montaruli B; Bertero MT; Carignola R; Roccatello D;
    Lupus; 2016 Apr; 25(5):479-85. PubMed ID: 26657216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct oral anticoagulants in antiphospholipid syndrome: a real life case series.
    Betancur JF; Bonilla-Abadía F; Hormaza AA; Jaramillo FJ; Cañas CA; Tobón GJ
    Lupus; 2016 May; 25(6):658-62. PubMed ID: 26743321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current management of antiphospholipid syndrome-related thrombosis.
    Puente D; Pombo G; Forastiero R
    Expert Rev Cardiovasc Ther; 2009 Dec; 7(12):1551-8. PubMed ID: 19954317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiphospholipid syndrome.
    Cervera R
    Thromb Res; 2017 Mar; 151 Suppl 1():S43-S47. PubMed ID: 28262233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiphospholipid Syndrome On Cloud (APSOnCloud): web-based monitoring of oral anticoagulation.
    Nogueira F; Signorelli F; Levy RA
    Lupus; 2017 Feb; 26(2):179-185. PubMed ID: 27436335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiphospholipid syndrome - an update.
    Linnemann B
    Vasa; 2018 Oct; 47(6):451-464. PubMed ID: 30205764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring of anticoagulation in thrombotic antiphospholipid syndrome.
    Cohen H; Efthymiou M; Devreese KMJ
    J Thromb Haemost; 2021 Apr; 19(4):892-908. PubMed ID: 33325604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of patients with antiphospholipid syndrome with major bleeding after oral anticoagulant treatment.
    Castellino G; Cuadrado MJ; Godfrey T; Khamashta MA; Hughes GR
    Ann Rheum Dis; 2001 May; 60(5):527-30. PubMed ID: 11302880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perioperative management of patients with antiphospholipid syndrome: a single-center experience.
    Atisha-Fregoso Y; Espejo-Poox E; Carrillo-Maravilla E; Pulido-Ramírez AL; Lugo Baruqui D; Hernández-Molina G; Cabral AR
    Rheumatol Int; 2017 Jul; 37(7):1159-1164. PubMed ID: 28474094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostics and treatment of thrombotic antiphospholipid syndrome (APS): A personal perspective.
    Pengo V; Denas G
    Thromb Res; 2018 Sep; 169():35-40. PubMed ID: 30007134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How I treat anticoagulant-refractory thrombotic antiphospholipid syndrome.
    Cohen H; Isenberg DA
    Blood; 2021 Jan; 137(3):299-309. PubMed ID: 32898856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombotic risk in the antiphospholipid syndrome.
    Lim W
    Semin Thromb Hemost; 2014 Oct; 40(7):741-6. PubMed ID: 25299926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombotic Management of Antiphospholipid Syndrome: Towards Novel Targeted Therapies.
    Islam MA; Alam F; Wong KK; Kamal MA; Gan SH
    Curr Vasc Pharmacol; 2017; 15(4):313-326. PubMed ID: 28056758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.